SENETEK PLC /ENG/
10-Q, EX-27.1, 2000-11-08
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: SENETEK PLC /ENG/, 10-Q, 2000-11-08
Next: EMC CORP, 8-K, 2000-11-08



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONSOLIDATED
FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
CONSOLIDATED FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           1,556
<SECURITIES>                                         0
<RECEIVABLES>                                    1,055
<ALLOWANCES>                                         0
<INVENTORY>                                        573
<CURRENT-ASSETS>                                 3,291
<PP&E>                                           3,799
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  10,302
<CURRENT-LIABILITIES>                            6,162
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         4,720
<OTHER-SE>                                    (10,600)
<TOTAL-LIABILITY-AND-EQUITY>                    10,302
<SALES>                                          2,981
<TOTAL-REVENUES>                                 2,981
<CGS>                                            1,178
<TOTAL-COSTS>                                    1,178
<OTHER-EXPENSES>                                 4,432
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,527
<INCOME-PRETAX>                                (4,126)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (4,126)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (4,126)
<EPS-BASIC>                                     (0.07)
<EPS-DILUTED>                                   (0.07)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission